Article Information
History
- August 3, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Zachary J. Madewell, PhD1,*,
- Nathan Graff, MS2,
- Velma K. Lopez, PhD1,
- Dania M. Rodriguez, MS1,
- Joshua M. Wong, MD1,
- Panagiotis Maniatis, MS3,
- Freddy A. Medina1,
- Jorge L. Muñoz, PhD1,
- Melissa Briggs-Hagen, MD2,
- Laura E. Adams, DVM1,
- Vanessa Rivera-Amill, PhD4,
- Gabriela Paz-Bailey, MD, PhD1 and
- Chelsea G. Major, MPH1
- 1Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico
- 2Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia
- 3Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
- 4Ponce Health Sciences University/Ponce Research Institute, Ponce, Puerto Rico
- ↵*Corresponding author
: Zachary J. Madewell Corresponding author Email:
ock0{at}cdc.gov
Posted August 03, 2024.
Durability of SARS-CoV-2 IgG Antibodies: Insights from a Longitudinal Study, Puerto Rico
